PLYMOUTH, Mass., June 21 /PRNewswire/ -- Harvest Technologies announced
that it has expanded its licensing agreement with DePuy AcroMed, Inc., a
Johnson & Johnson company. The agreement provides DePuy AcroMed with exclusive
rights for distribution in Worldwide Markets for the Harvest's SmartPReP
Platelet Concentrate System, sold under the Symphony name in the
Harvest's SmartPReP System, using a patient's own blood during surgery,
harvests and concentrates platelet-rich plasma which contain naturally
occurring growth factors and wound healing proteins. The SmartPReP(TM) is fast
and easy to use and requires only a small blood sample to produce consistently
high levels of platelet concentrate. Depuy has been successfully marketing the
Symphony System in the US Market during the past two years.
"Our expanded alliance with DePuy AcroMed is a natural extension of the
success our two organizations have experienced in the US market, states Gary
Tureski, co-founder and president of Harvest Technologies Corporation. "It
will introduce Harvest's technologies into the worldwide orthopedic market
place. This agreement also allows Harvest to focus its resources on developing
the non-orthopedic soft tissue markets in Plastic, ENT, Oral Surgery and in
the Acute Wound Care markets worldwide.
Harvest Technologies Corporation designs, develops and markets unique
systems that target the demand for surgical solutions using the patient's own
blood. The company has its offices in Plymouth, MA as well as Munich, Germany.
DePuy AcroMed, a Johnson & Johnson company, is based in Raynham,
Massachusetts. The company is a spinal industry leader focused on the design,
development, manufacturing and marketing of spinal products used by
orthopaedic surgeons and neurosurgeons worldwide.
Kevin Benoit, General Manager
Harvest Technologies Corp.
MAKE YOUR OPINION COUNT - Click Here
SOURCE Harvest Technologies Corporation